NANOVIRICIDES, INC. — Director's Dealing 2017

Feb 3, 2017

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: NANOVIRICIDES, INC. (NNVC)
CIK: 0001379006
Period of Report: 2017-02-01

Reporting Person: BONIUK MILTON (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2017-02-01	Common Stock, par value $0.001 per share	J	605474	$0.00	Disposed	0	Indirect

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2017-02-01	Unsecured 8% Coupon Series B Convertible Debentures	$3.50	J	1	Disposed	2017-01-31	Common Stock, par value $0.001 (571428)	Indirect

Footnotes

F1: Effective February 1, 2017, the Reporting Person no longer holds voting and dipositive control over the shares of common stock owned by Boniuk Charitable Foundation (the "Foundation") reported in this Form 4. This Form 4 solely reflects the relinquishment of that control by the Reporting Person. The Foundation is a tax-exempt organization under Section 501(c)(3) of the Internal Revenue Code. No part of the Foundation's net income may inure to the benefit of the Reporting Person or any other private person, and the assets of the Foundation may not revert to private ownership if the Foundation is dissolved. Accordingly, the Reporting Person does not and did not have a pecuniary interest in the shares held by the Foundation and such shares no longer will be reported as beneficially owned by the Reporting Person for purposes of Section 16(a).

F2: Does not include: (a) 1,240,063 shares of Common Stock and warrants to purchase an additional 571,428 shares of Common Stock held by the Reporting Person and his wife; (b) 309,844 shares of Common Stock, 952,381 shares of Common Stock issuable upon conversion of a 10% Coupon Series C Convertible Debenture, or 187,000 shares of Series A Preferred Stock held by Milton Boniuk IRA, convertible into 654,500 shares of common stock, which are not readily convertible; or (c) 976,902 shares of Common Stock , warrants to purchase an additional 285,714 shares of Common Stock, or an indeterminate number of shares of Common Stock issuable upon conversion of debentures held by Boniuk Interests, Ltd.; Dr. Boniuk holds voting and dispositive power over Boniuk Interests Ltd. and the Milton Boniuk IRA.

F3: Reflects the maturity date of debenture.

F4: Based upon the conversion price of $3.50.